<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/172"/><api:result><api:object category="publication" id="172" last-affected-when="2024-03-14T05:33:11.37+00:00" last-modified-when="2024-03-14T05:33:11.37+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/172" created-when="2010-05-17T13:46:12.607+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>1999-03-23</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="94701" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0032988193" last-modified-when="2020-08-19T20:50:44.37+01:00"><api:citation-count>4</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bone disease is a frequent manifestation of multiple myeloma, and results in considerable morbidity. In this review we summarise the current theories as to the mechanism of bony destruction in this disease and discuss the interrelationships between the malignant plasma cells and those cells responsible for bone remodelling, i.e. the osteoclasts and osteoblasts. The bisphosphonates are a long established group of drugs known to have inhibitory effects on osteoclast activity, and in common use for osteoporosis and Paget's disease. Their role in myeloma is less clear. Several clinical studies, including phase III randomised placebo controlled trials, have been reported in recent years. Although these have tended to show a benefit for bisphosphonate treatment, we have not yet identified the most appropriate use of these agents. Two of the clinical trials have suggested that bisphosphonates may also have a beneficial effect on the underlying disease, a tantalising theory which has been supported with some early laboratory data.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London School of Medicine</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005558171</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London School of Medicine</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">26635094100</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10192885</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0369-8114</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974351"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Pathologie Biologie</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>178</api:begin-page><api:end-page>181</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>23</api:day><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Bisphosphonates in multiple myeloma</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>47</api:text></api:field></api:native></api:record><api:record format="native" id="172" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10192885" last-modified-when="2020-04-29T00:30:30.32+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bone disease is a frequent manifestation of multiple myeloma, and results in considerable morbidity. In this review we summarise the current theories as to the mechanism of bony destruction in this disease and discuss the interrelationships between the malignant plasma cells and those cells responsible for bone remodelling, i.e. the osteoclasts and osteoblasts. The bisphosphonates are a long established group of drugs known to have inhibitory effects on osteoclast activity, and in common use for osteoporosis and Paget's disease. Their role in myeloma is less clear. Several clinical studies, including phase III randomised placebo controlled trials, have been reported in recent years. Although these have tended to show a benefit for bisphosphonate treatment, we have not yet identified the most appropriate use of these agents. Two of the clinical trials have suggested that bisphosphonates may also have a beneficial effect on the underlying disease, a tantalizing theory which has been supported with some early laboratory data.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Haematology, Imperial College School of Medicine, London, England.</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10192885</api:text></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0369-8114</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974351"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Pathol Biol (Paris)</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Bone Diseases</api:keyword><api:keyword scheme="mesh">Bone Resorption</api:keyword><api:keyword scheme="mesh">Diphosphonates</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Multiple Myeloma</api:keyword><api:keyword scheme="mesh">Osteoblasts</api:keyword><api:keyword scheme="mesh">Osteoclasts</api:keyword><api:keyword scheme="mesh">Plasma Cells</api:keyword><api:keyword scheme="mesh">Randomized Controlled Trials as Topic</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>France</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>178</api:begin-page><api:end-page>181</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>19</api:day><api:month>5</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Bisphosphonates in multiple myeloma.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>47</api:text></api:field></api:native></api:record><api:record format="native" id="858408" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10192885" last-modified-when="2024-02-14T00:30:52.07+00:00"><api:citation-count>2</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bone disease is a frequent manifestation of multiple myeloma, and results in considerable morbidity. In this review we summarise the current theories as to the mechanism of bony destruction in this disease and discuss the interrelationships between the malignant plasma cells and those cells responsible for bone remodelling, i.e. the osteoclasts and osteoblasts. The bisphosphonates are a long established group of drugs known to have inhibitory effects on osteoclast activity, and in common use for osteoporosis and Paget's disease. Their role in myeloma is less clear. Several clinical studies, including phase III randomised placebo controlled trials, have been reported in recent years. Although these have tended to show a benefit for bisphosphonate treatment, we have not yet identified the most appropriate use of these agents. Two of the clinical trials have suggested that bisphosphonates may also have a beneficial effect on the underlying disease, a tantalizing theory which has been supported with some early laboratory data.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Haematology, Imperial College School of Medicine, London, England.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-7102-2413</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1768-3114</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974351"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10192885</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0369-8114</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974351"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Pathologie-biologie</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Plasma Cells</api:keyword><api:keyword scheme="mesh">Osteoclasts</api:keyword><api:keyword scheme="mesh">Osteoblasts</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Multiple Myeloma</api:keyword><api:keyword scheme="mesh">Bone Diseases</api:keyword><api:keyword scheme="mesh">Bone Resorption</api:keyword><api:keyword scheme="mesh">Diphosphonates</api:keyword><api:keyword scheme="mesh">Randomized Controlled Trials as Topic</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>178</api:begin-page><api:end-page>181</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>8</api:day><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Bisphosphonates in multiple myeloma.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>47</api:text></api:field></api:native></api:record><api:record format="native" id="2920822" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1074354479" last-modified-when="2023-11-26T11:38:17.483+00:00"><api:citation-count>3</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0753003365.31</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0756766474.08</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10192885</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0369-8114</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974351"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Current Research in Translational Medicine</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc">Cancer</api:keyword><api:keyword scheme="rcdc">Clinical Research</api:keyword><api:keyword scheme="rcdc">Hematology</api:keyword><api:keyword scheme="rcdc">Clinical Trials and Supportive Activities</api:keyword><api:keyword scheme="rcdc">Osteoporosis</api:keyword><api:keyword scheme="rcdc">Rare Diseases</api:keyword><api:keyword scheme="hrcs-rac">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-hc">Musculoskeletal</api:keyword><api:keyword scheme="hrcs-hc">Cancer</api:keyword><api:keyword scheme="mesh">Bone Diseases</api:keyword><api:keyword scheme="mesh">Bone Resorption</api:keyword><api:keyword scheme="mesh">Diphosphonates</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Multiple Myeloma</api:keyword><api:keyword scheme="mesh">Osteoblasts</api:keyword><api:keyword scheme="mesh">Osteoclasts</api:keyword><api:keyword scheme="mesh">Plasma Cells</api:keyword><api:keyword scheme="mesh">Randomized Controlled Trials as Topic</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>178</api:begin-page><api:end-page>181</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.09</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Bisphosphonates in multiple myeloma.</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>47</api:text></api:field></api:native></api:record><api:record format="native" id="239827" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000079185300012" last-modified-when="2024-03-14T05:33:11.38+00:00"><api:citation-count>4</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000079185300012&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">177AP</api:identifier><api:identifier scheme="pubmed">10192885</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0369-8114</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974351"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PATHOLOGIE BIOLOGIE</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>myeloma</api:keyword><api:keyword>bone disease</api:keyword><api:keyword>bisphosphonates</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>178</api:begin-page><api:end-page>181</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Bisphosponates in multiple myeloma</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>47</api:text></api:field></api:native></api:record><api:record format="native" id="22351" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000079185300012" last-modified-when="2014-07-25T11:01:16.057+01:00"><api:citation-count>4</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0369-8114</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974351"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PATHOL BIOL</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>myeloma</api:keyword><api:keyword>bone disease</api:keyword><api:keyword>bisphosphonates</api:keyword><api:keyword>BONE-RESORPTION</api:keyword><api:keyword>DICHLOROMETHYLENE DIPHOSPHONATE</api:keyword><api:keyword>SKELETAL MORBIDITY</api:keyword><api:keyword>CELL-LINES</api:keyword><api:keyword>PAMIDRONATE</api:keyword><api:keyword>TRIAL</api:keyword><api:keyword>BISPHOSPHONATES</api:keyword><api:keyword>CLODRONATE</api:keyword><api:keyword>EVENTS</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>178</api:begin-page><api:end-page>181</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Bisphosponates in multiple myeloma</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>47</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Bone Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Bone Resorption</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Diphosphonates</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Multiple Myeloma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Osteoblasts</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Osteoclasts</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Plasma Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Randomized Controlled Trials as Topic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Plasma Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Osteoclasts</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Osteoblasts</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Multiple Myeloma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Bone Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Bone Resorption</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Diphosphonates</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Randomized Controlled Trials as Topic</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Hematology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Trials and Supportive Activities</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Osteoporosis</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Rare Diseases</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Musculoskeletal</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Bone Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Bone Resorption</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Diphosphonates</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Multiple Myeloma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Osteoblasts</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Osteoclasts</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Plasma Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Randomized Controlled Trials as Topic</api:keyword><api:keyword origin="record-data" source="wos-lite">myeloma</api:keyword><api:keyword origin="record-data" source="wos-lite">bone disease</api:keyword><api:keyword origin="record-data" source="wos-lite">bisphosphonates</api:keyword><api:keyword origin="record-data" source="wos">myeloma</api:keyword><api:keyword origin="record-data" source="wos">bone disease</api:keyword><api:keyword origin="record-data" source="wos">bisphosphonates</api:keyword><api:keyword origin="record-data" source="wos">BONE-RESORPTION</api:keyword><api:keyword origin="record-data" source="wos">DICHLOROMETHYLENE DIPHOSPHONATE</api:keyword><api:keyword origin="record-data" source="wos">SKELETAL MORBIDITY</api:keyword><api:keyword origin="record-data" source="wos">CELL-LINES</api:keyword><api:keyword origin="record-data" source="wos">PAMIDRONATE</api:keyword><api:keyword origin="record-data" source="wos">TRIAL</api:keyword><api:keyword origin="record-data" source="wos">BISPHOSPHONATES</api:keyword><api:keyword origin="record-data" source="wos">CLODRONATE</api:keyword><api:keyword origin="record-data" source="wos">EVENTS</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Microbiology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3202 Clinical sciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0369-8114" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974351" title="Pathologie Biologie"><api:records><api:record source-name="summary"><api:title>Pathologie Biologie</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/172/relationships"/></api:object></api:result></api:response>